The FDA has approved some drugs to ease the symptoms of Alzheimer’s dementia: donepezil (Aricept), mirtazapine (Remeron), tacrine (Cognex, which was discontinued in the United States because of its link with acute liver damage), galantamine (Reminyl or Razadyne), rivastigmine (Exelon), memantine (Ebixa or Namenda), and Namzaric, which combines donepezil with memantine. None of them slows or stops the progression of Alzheimer’s disease.
